Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118078 · ClinicalTrials.gov registry record
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 185
- Enrollment target
NCT01118078 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 185 participants.
The verdict
NCT01118078 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 185 participants
- Enrollment target
Study Summary
This research study is studying biomarkers in tissue samples from patients with high-risk Wilms tumor. Studying samples of tissue from patients with cancer in the laboratory may help doctors to learn more about changes that occur in DNA and identify biomarkers related to cancer.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC DNA methylation analysis
- OTHER diagnostic laboratory biomarker analysis
- GENETIC reverse transcriptase-polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118078
The ClinicalTrials.gov registry entry for NCT01118078 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01118078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118078 about?
NCT01118078 is a clinical study titled "Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor". This research study is studying biomarkers in tissue samples from patients with high-risk Wilms tumor. Studying samples of tissue from patients with cancer in the laboratory may help doctors to learn more about changes that occur in DNA and identify biomarkers related to cancer.
What is the current status of trial NCT01118078?
This trial is currently completed. The enrollment target is 185 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01118078?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), DNA methylation analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER), reverse transcriptase-polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT01118078?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.